PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#Rabeprazole ×

UPDATED
Actualizaciones regulatorias
30 ago 2026•1 min de lectura
FDA Approves ANDA076885 for Rabeprazole Sodium
FDA has approved ANDA076885 for Rabeprazole Sodium oral delayed‑release tablets (20 mg) sponsored by Pharmobedient, with multiple labeling submissions approved between 2013 and 2023.